KIMBERLY COLLINS: Open Payments
NPI 1932203262 · GRAVOIS MILLS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 17 payments from 11 companies in 2025. Trend: 2023 $396 · 2024 $359 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $93 |
| Dexcom, Inc. | 3 | $72 |
| Boston Scientific Corporation | 1 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Amgen Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $25 |
| Viatris Specialty LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
Products named: Dexcom G6 Transmitter, AVEIR, WATCHMAN Access System, FREESTYLE LIBRE, Jornay PM, BREZTRI, BEYFORTUS, YUPELRI.
Industry payments across MO — which companies pay providers there.
